Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCC4 | O15439 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 5/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.52 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.52 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.44 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.44 |
| ▸ | PPARG | P37231 | 6/20 | 0.43 |
| ▸ | PPARD | Q03181 | 6/20 | 0.43 |
| ▸ | PPARA | Q07869 | 6/20 | 0.43 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | TLR2 | O60603 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7672304 | 1.00 | ABCC4 (0.54) | ABCC4MAPTPRMT1TSHRLMNA | |
| SCHEMBL7673904 | 1.00 | ABCC4 (0.54) | ABCC4MAPTPRMT1TSHRLMNA | |
| SCHEMBL7674677 | 1.00 | ABCC4 (0.54) | ABCC4MAPTPRMT1TSHRLMNA | |
| SCHEMBL7670330 | 1.00 | ABCC4 (0.54) | ABCC4MAPTPRMT1TSHRLMNA | |
| SCHEMBL7666381 | 1.00 | ABCC4 (0.54) | ABCC4MAPTPRMT1TSHRLMNA | |
| SCHEMBL5334032 | 0.91 | — | — | |
| SCHEMBL27997860 | 0.89 | ABCC4 (0.45) | ABCC4MAPTPRMT1TSHRLMNA | |
| SCHEMBL30195051 | 0.89 | ABCC4 (0.45) | ABCC4MAPTPRMT1TSHRLMNA | |
| SCHEMBL19059496 | 0.85 | EPHX2 (0.53) | ABCC4MAPTPRMT1TSHRLMNA | |
| SCHEMBL770728 | 0.82 | PRMT1 (0.58) | ABCC4MAPTPRMT1TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3919525-B1 | POLAR GROUP-CONTAINING OLEFIN COPOLYMER | JAPAN POLYETHYLENE CORP (JP) | 2023-08-09 | — | — | EP | disclosed |
| EP-3694503-B1 | NOVEL SUBSTITUTED CYCLOBUTYLPYRIDINE AND CYCLOBUTYLPYRIMIDINE COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) INHIBITORS | MERCK SHARP & DOHME LLC (US) | 2023-08-02 | — | — | EP | disclosed |
| US-20220106471-A1 | POLAR GROUP-CONTAINING OLEFIN COPOLYMER | JAPAN POLYETHYLENE CORPORATION (JP) | 2022-04-07 | — | — | US | disclosed |
| EP-3919525-A1 | POLAR GROUP-CONTAINING OLEFIN COPOLYMER | Japan Polyethylene Corporation (JP) | 2021-12-08 | — | — | EP | disclosed |
| EP-3524273-A1 | CYSTEINE MODIFIED ANTIBODY-DRUG CONJUGATE AND PREPARATION METHOD THEREOF | Sichuan Baili Pharm Co., Ltd. (CN) | 2019-08-14 | — | — | EP | disclosed |
| US-20020091254-A1 | Stabilizing and/or lowering the color number of alkenyl compounds | BASF AKTIENGESELLSCHAFT (DE) | 2002-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020091254-A1 | Stabilizing and/or lowering the color number of alkenyl compounds | SOD1, NOX4, CAT | ABCC4 3635/4885MAPT 673/4885PRMT1 2525/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.